Publications
- Molecular biomarkers in multiple sclerosis2022 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Superiority of ceftazidime off-label high-dose regimen in PK/PD target attainment during treatment of extensively drug-resistant Pseudomonas aeruginosa infections in cancer patients2023 | First Faculty of Medicine, Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Detection of galanin receptors in the spinal cord in experimental autoimmune encephalomyelitis2023 | First Faculty of Medicine
- Population pharmacokinetic model-based dosing proposal for ampicillin prophylaxis in cardiac surgery patients with cardiopulmonary bypass2023 | First Faculty of Medicine
- Intraperitoneally Administered Vancomycin in Patients with Peritoneal Dialysis-Associated Peritonitis: Population Pharmacokinetics and Dosing Implications2023 | First Faculty of Medicine
- Targeting leukocytes in multiple sclerosis: Therapeutic perspectives2023 | First Faculty of Medicine
- Population pharmacokinetics-pharmacodynamics of fondaparinux in dialysis-dependent chronic kidney disease patients undergoing chronic renal replacement therapy2022 | First Faculty of Medicine, Faculty of Pharmacy in Hradec Králové
- Severity parameters for asphyxia or hypoxic-ischemic encephalopathy do not explain inter-individual variability in the pharmacokinetics of phenobarbital in newborns treated with therapeutic hypothermia2022 | First Faculty of Medicine
- Edaravone Attenuates Disease Severity of Experimental Auto-Immune Encephalomyelitis and Increases Gene Expression of Nrf2 and HO-12022 | First Faculty of Medicine
- Population Pharmacokinetics of Prophylactic Cefazolin in Cardiac Surgery with Standard and Minimally Invasive Extracorporeal Circulation2022 | First Faculty of Medicine
Loading network view...